Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care...

34
The HIP Trial is funded by the European Commission within the 7th Framework Programme Functional Echocardiography Targeted neonatal echocardiography (TNE) Point of care echocardiography (POCT ECHO) Kyiv March 2013 Jan Širc Institute for the Care of Mother and Child, Prague, Czech Republic Third Faculty of Medicine, Charles University, Prague, Czech Republic

description

International conference «Actual approaches to the extremely preterm babies: International experience and Ukrainian realities» (Kyiv, Ukraine, March 5-6, 2013)

Transcript of Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care...

Page 1: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Functional Echocardiography Targeted neonatal echocardiography (TNE)

Point of care echocardiography (POCT ECHO)

Kyiv March 2013

Jan Širc

Institute for the Care of Mother and Child, Prague, Czech Republic

Third Faculty of Medicine, Charles University, Prague, Czech Republic

Page 2: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Rule out structural abnormality

• Need for direct measure of cardiovascular

function

• Effect of treatment

• Need for serial assessments

• Poor availability of cardiologists 24/7

Why should we be able to perform

and interpret TNE

Page 3: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

www.neonatalechoskills.com

Increasing use of TNE in NICU

Enough of theoretical informations

Need for good training !

Page 4: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Page 5: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Find a supervisor

- neonatologist with experience in TNE

- pediatric cardiologist

• 24/7 access to ultrasound machine

• Congenital heart defect has to be excluded in the

first scan

Basic rules of TNE

Page 6: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Suspected patent ductus arteriosus (PDA)

• The cyanosed newborn

- suspected persistent pulmonary hypertension

- excluding structural heart disease

• The infant with heart failure, hypotension or shock

• Newborn with heart murmur

• Central line placement

• Suspected effusion

• Suspected thrombosis

Indications for TNE

Page 7: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Left ventricular function

• Right ventricular function

• Ductal shunting

• Atrial shunting

• Pulmonary artery pressure

• Measurement of blood flow and cardiac output

• Superior vena cava flow

Not all have to be part of standard TNE ECHO

Components of TNE

Page 8: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• FS – derived from an long-axis or short axis view

• M-Mode at the mitral leaflets tips

• Beam perpendicular to septum

• One of the most reproducible measurements

LV systolic function – Fractional shortening

Page 9: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

LVEDD – left ventricular end-

diastolic diameter

LVESD – left ventricular end-

systolic diameter

Normal values

Term babies 25-41%

Preterm 23-40%

LV systolic function – Fractional shortening

FS = [(LVEDD-LVESD)/LVEDD] x 100

LVEDD LVESD

Page 10: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

LVET – left ventricular ejection

time, from the closure to the

opening of the mitral valve

Less sensitive to dimensional

discrepancies

Normal values 1.5 ± 0.04

circumferences/s

LV systolic function – mVCFs

mVCFs - Mean velocity of circumferential fiber shortening

mVCFs = mean [(LVEDD-LVESD)/LVEDD] x LVET

LVET

Page 11: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Ejection fraction (EF) – the proportion of ventricular contents

ejected during systole

EF = [(LVEDD 3 -LVESD 3)/LVEDD 3] x 100%

• Any errors in measurements are cubed

• Changes in shape of the ventricular cavity

Fractional shortening should be prefered

LV systolic function – Ejection fraction

Page 12: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Ventricular filling velocities

From four chamber view

Ratio of E:A wave

Diastolic function – blood inflow

E A

Page 13: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Changes during the first week of life from dominance of filling during

atrial contraction (A wave) to dominance of early contraction (E wave)

• Progressive increase of E wave and E/A ratio

• More pronounced in preterm infants (developmental changes,

diastolic dysfunction after birth?)

• Diastolic dysfunction – reduced both waves, dominant A wave

• Unusable in high heart rates – merge of waves

Diastolic function – blood inflow

Normal values term > 0.7:1

(E:A) preterm > 0.6:1

Page 14: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• MPI (= Tei index) - Myocardial

performance index

• From adjusted four chamber

view – to get inflow and outflow

• Combines the isovolumic

relaxation and contraction

times

• Corrected for the ejection time

LV systolic/diastolic function – MPI

Page 15: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Less usable in high heart

rates

• Influenced by preload and

afterload

Normal values 0.25 – 0.38

Poor systolic and/or diastolic

function > 0.38

LV systolic/diastolic function – MPI

ICT IRT

ET

Page 16: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Systolic and diastolic function

• Measuring of myocardium movement in 4 chamber view

• 2 variables peak velocities – S´, E´, A´ wave

time intervals – IVC, IVR, TEI index (MPI index)

Tissue Doppler

E´ A´

Page 17: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Tissue Doppler

TISSUE DOPPLER ECHOCARDIOGRAPHY

ASSESSMENT OF MYOCARDIAL FUNCTION IN

EARLY NEONATAL PERIOD

Sirc J, Semberova J, Stranak Z

ECPM Paris 2013

Page 18: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Strain

• Strain rate

• Speckle tracking

Used in cardiology or for

research

Other modalities

Page 19: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Ductal diameter

• Direction of blood flow, flow pattern – restricted, wide open

• Assesment of hemodynamic significance

1. diastolic flow in abdominal aorta – steal or not

2. diastolic flow in left pulmonary artery (more than 0:2 m/s)

3. Left atrium to aortic root ratio - LA/Ao ratio (more than 1.5)

4. Flow pattern in pulmonary artery – turbulent flow

5. Left heart overload, mitral regurgitation

Ductal shunting

Page 20: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• High incidence

• From subcostal four chamber view or short axis

view

Atrial shunting

Page 21: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Usually low velocity flow – colour Doppler, pulsed wave

• Dominant shunting is left to right (up to 30% of right to left is

normal)

• Pure right to left shunt – congenital heart disease, pulmonary

hypertension of the newborn (PPHN)

• Large atrial shunting increases right ventricular output,

decreases LA/Ao ratio

Atrial shunting

Page 22: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

1. From ductal shunting

• Ductal flow reflects relation of

systemic and pulmonary BP

• Derived from colour Doppler,

pulsed/continuous Doppler

• Supra-systemic pressure when

right-to-left flow ≥ 30% of cardiac

cycle

• bidirectional PDA flow is typical for

first hours after birth, changes to L-

R as PVR decreases

Pulmonary artery pressure (PAP)

Page 23: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

2. From tricuspid regurgitation jet

• Modified Bernoulli equation

PAP = 4 x velocity2 + 5 (atrial

pressure)

• Most accurate of the indirect

methods

• 50% of a babies will not have

tricuspidal regurgitation

Pulmonary artery pressure (PAP)

Page 24: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Systemic blood flow ≠ cardiac output when atrial

and ductal shunt is present

Ductal shunt – increases left ventricular output

Atrial shunt – increases right ventricular output

Assessment of systemic blood flow

Blood flow

• VTI – velocity time integral, area

under the systolic envelope

• Cross sectional area

• Heart rate

• Infants weight

Page 25: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Measuring of ascending aorta

• Diameter – from long axis view, end-systolic internal

(trailing edge to leading edge) diameter beyond the

coronary sinus

• Velocity – from apical or suprasternal view, average VTI

from 5 cardiac cycles

LVO = [p x (d2/4) x VTI x HR] / weight

Left ventricular output - LVO

Page 26: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Left ventricular output - LVO

Normal values 150-300 ml/kg/min

Page 27: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• RVO represent systemic blood flow more than LVO in preterm

infants with PDA and FOA

• Measuring in the main pulmonary artery

• Diameter – low parasternal view, 2-D image at the insertion of

pulm.valve leaflets in end-systole

• Velocity – just beyond the valve leaflets

RVO = [p x (d2/4) x VTI x HR] / weight

Right ventricular output - RVO

Page 28: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Right ventricular output - RVO

Normal values 150-300 ml/kg/min

Page 29: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Partial cardiac input. Blood from upper body. 70-80% is from

brain

• Not confounded by shunts

• Diameter – parasternal view before entry to right atrium

Average value from maximal and minimal diameter

• Velocity – subcostal view. Average from 10 cycles

Superior vena cava flow – SVC flow

SVC = [p x (d2/4) x VTI x HR] / weight

Normal values 40-120 ml/kg/min in VLBW

Page 30: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Superior vena cava flow – SVC flow

• Diameter from parasternal view – 2D or M-mode

• Flow – subcostal view, pulsed Doppler

Page 31: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

SVC flow

Page 32: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Appropriate placement – PICC line, UVC, UAC

• Identification of complications – thrombosis, abnormal

position, line fracture, embolization, vessel occlusion

• Flush with normal saline may be helpful

• Advantage – routine X-Ray after insertion is not

necessary

Central line placement

Page 33: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

• Suspected effusion

pericardial - from 4 chamber view, long axis view

pleural

pneumopericard – unable to see the heart, echo shadow of air

• Suspected thrombosis

Another abnormal conditions

Page 34: Functional Echocardiography. Targeted neonatal echocardiography (TNE). Point of care echocardiography (POCT ECHO).

The HIP Trial is funded by the European Commission within the 7th Framework Programme

Thanks a lot for your attention